INTERNATIONAL PATENT: AMUNIX PHARMACEUTICALS, INC., BIOVERATIV THERAPEUTICS INC. FILES APPLICATION FOR "ANTIBODIES AND ASSAYS FOR DETERMINING CLOTTING FACTOR VIII ACTIVITY"

GENEVA, July 3 -- AMUNIX PHARMACEUTICALS, INC. (500 Ellis StreetMountain view, California 94003), BIOVERATIV THERAPEUTICS INC. (225 Second AvenueWaltham, Massachusetts 02451) filed a patent application (PCT/US2024/060680) for "ANTIBODIES AND ASSAYS FOR DETERMINING CLOTTING FACTOR VIII ACTIVITY" on Dec 18, 2024. With publication no. WO/2025/137044, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CAMPBELL, Andrew (c/o Sanofi, Patent Department450 Water StreetCambridge, Massachusetts 02141), SETH CHHABRA, Ekta (c/o Sanofi, P...